TGR analysis in phase I clinical trials--response.
Authors' Affiliations: Departments of Medical Oncology, Biostatistics and Epidemiology, and Innovative Therapeutics and Early drug development; and INSERM U981, University Paris Sud, Gustave Roussy, France.
Charles
C
Ferté
Serge
S
Koscielny
Jean-Charles
JC
Soria
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents